Fulgent Genetics, Inc. (FLGT) Profit Margins
Over the twelve months to 2026-06-30, Fulgent Genetics, Inc. (FLGT) had gross margin 35.6%, operating margin -37.7%, net margin -26.0%, free cash flow margin -32.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FLGTFulgent Genetics, Inc.Follow FLGT — free
—
Price chart with a free account
- Market cap
- 553.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.2% | 54.3% | 49.9% | 56.6% | 78.7% | 78.3% | 59.3% | 36.1% | 37.8% | 40.6% | 35.6% | |
| Operating margin | 5.0% | -18.6% | -23.7% | -1.3% | 68.8% | 68.1% | 28.8% | -67.6% | -26.1% | -28.2% | -37.7% | |
| Net margin | -29.3% | -13.4% | -26.3% | -1.3% | 50.8% | 51.1% | 23.2% | -58.0% | -15.1% | -18.8% | -26.0% | |
| FCF margin | 3.4% | -8.4% | -14.0% | 13.3% | 25.0% | 51.9% | 37.9% | 1.7% | -6.8% | -38.5% | -32.0% |
USD billions · SEC XBRL
Fulgent Genetics, Inc. — questions
- What is Fulgent Genetics, Inc.'s gross margin?
- 35.6% over the twelve months to 2026-06-30.
- What is Fulgent Genetics, Inc.'s operating margin?
- -37.7% over the twelve months to 2026-06-30.
- What is Fulgent Genetics, Inc.'s net profit margin?
- -26.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Fulgent Genetics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.